BehaveNet^® Clinical Capsule™:

drug: methsuximide

• Clinical class: anticonvulsant
• Chemical class: succinimide
• CSA schedule: none
• DEA number: none
• Also: methosuximide

U.S. Preparations:

• Celontin^® (Pfizer) FDA approved: for treatment of refractory absence (petit mal) epilepsy.

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2006 BehaveNet®